期刊文献+

经直肠内线圈1HMRS对前列腺癌的诊断价值 被引量:1

The value of 1H Proton magnetic resonance spectroscopy with a endorectal coil in the diagnosis of prostatic carcinoma
下载PDF
导出
摘要 目的:探讨1H MRS对前列腺癌的诊断价值。方法:经穿刺活检、手术病理证实的40例前列腺癌患者,行轴位高分辨T2WI和经直肠内线圈行1H MRS扫描,分析前列腺癌FSET2WI及1H MRS的影像表现。结果:1H-MRS波谱分析测得前列腺癌区(Choline+Creation)/Citrate平均值为2.52±1.24,而周围正常前列腺组织的平均值为0.47±0.17,并具有显著统计学差异;FSET2WI扫描检出29例前列腺癌,敏感度为72.5%,1H MRS检出了35例前列腺癌,敏感性为87.5%(P<0.01)。结论:经直肠内线圈1H MRS可对前列腺癌做出准确诊断,可用于前列腺癌的筛查。 Objective: To investigate the effect of endorectal 1 H-MRS on prostate cancer. Methods: 40 cases with pathology-proved prostate cancer were studied in which transverve high-spatial-resolution T2-weighted MR imaging and MR spectroscopic images were obtained. The MR examinations were evaluated and the MR and 3D 1 H-MRS findings were analyzed. Results:The citrate to creatine pins choline was 2.52 ± 1.24 in the regions of cancer prostate and 0.47- 0.17 in the regions of normal prostate tissue. The difference in ratio between cancer and normal prostate tissue was statistically significant ( P 〈 0.01). The MR T2WI scan showed a sensivity of 72.5% (29/40) and 87.5 % (35/40) in 1H-MRS ( P 〈 0.01). Conclusion: Diagnosis of prostatic carcinoma using endorectal 1H-MRS is highly precise, and is in favor of cancer detection in high-risk patient.
出处 《医学影像学杂志》 2008年第5期525-528,共4页 Journal of Medical Imaging
关键词 前列腺癌 磁共振成像 磁共振波谱 Prostate cancer Magnetic resonance iamging
  • 相关文献

参考文献9

  • 1Kaji Y, Wada A, Imaoka I, et al. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. Endorectal surface coil[J]. J Maga Reson Imaging, 2002, 16:697 - 706.
  • 2Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001,26:111 - 122.
  • 3Comud F, Ham T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of p T3 tumor and of positive endorectal MR imaging examination results [J]. Radiology, 2002, 224:203 - 210.
  • 4Cooper JF, Imfeld H. The role of citric acid in the physiology of the prostate preliminary report[J] .J Urol, 1959,81:157- 164.
  • 5Urhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer form benign prostatic hyperplasia and normal prostate peripheral zone detection via localized proton spectroscopy[J]. Urology, 1995,45:459 - 466.
  • 6Ackerstaff E, Pflug BR, Nelson SJ, et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells [J]. Cancer Res,2001,61:3599 - 3603.
  • 7Males RG, Vigneron DB, Star-Lack J, et al. Clinical applications of BASING and spectral/spatial water and lipid suppres-sion pulses for prostate cancer staging and localization by in vivo 3D H magaetic resonance spectroscopic imaging[J]. Magn Reson Med, 2000,43:17 - 22.
  • 8王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 9Casciani E, Polettini E, Bertini L et al. Prostate cancer evaluation with endorectal MR inaging and three-dimensional proton MRS imaging [J]. Radiol Med, 2004,108:330-541.

二级参考文献8

  • 1[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 2[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 3[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 4[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 5[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 6[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 7[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 8[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.

共引文献96

同被引文献19

  • 1王霄英,周良平,丁建平,王刚,肖江喜,蒋学祥.中国正常成年男性前列腺的MRS定量分析[J].中国医学影像技术,2003,19(5):576-578. 被引量:24
  • 2李岩,李建军,岑松,李传资,余宁,赵应满,许琴.MRS定量分析对于前列腺癌的诊断价值[J].中国医学影像技术,2005,21(12):1915-1917. 被引量:4
  • 3史浩,武乐斌,丁红宇,赵斌,王涛,杨贞振,邱秀玲,李慧华,曲蕾,魏煜龙.MR动态增强、扩散成像和波谱分析在前列腺癌诊断中的价值[J].中华放射学杂志,2006,40(7):678-683. 被引量:37
  • 4莱珀.前列腺疾病[M],英文影印版[M].北京:科学出版社,2001.535-546.
  • 5Ackerstaff E, Pflug BR, Nelson JB, et al. Detection of increasedcholine compounds with proton nuclear magnetic resonance spectrosco-py subsequent to malignant transformation of human prostatic epithelialcells [ J] . Cancer Res, 2001, 61(9) :3599-3603.
  • 6Shukla-Dave A, Hricak H, Eberhardt SC, et al. Chronic prostatitis:MR imaging and 1H MR spectroscopic imaging findings-initial obser-vations [J]. Radiology, 2004, 231(3) :717-724.
  • 7Chen AP, Cunningham CH, Kurhanewicz J, et al. High-resolution3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence [ J]. Magn Reson Imaging, 2006,24(7) :825-832.
  • 8Heijmink SW, Fiitterer JJ, Hambrock T, et al. Prostate cancer:body-array versus endorectal coil MR imaging at 3 T-comparison of im-age quality, localization, and staging performance [ J]. Radiology,2007,244(1) :184-95.
  • 9Hasumi M, Suzuki K, Oya N, et al. MH spectroscopy as a reliablediagnostic tool for localization of prostate cancer [ J ]. AnticancerRe-search,2002,22(2B) : 1205-1208.
  • 10Kumar R, Kumar M, Jagannathan NR, et al. Proton magnetic reso-nance spectroscopy with a body coil in the diagnosis of carcinomaprostate [J]. Urol Res ,2004,32 (1) :3640.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部